Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 193
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer.
Annals of Oncology.
Times cited: 21